David F. Stern PhD
Professor of Pathology; Associate Director, Shared Resources, Yale Cancer Center; Leader, Signal Transduction Research Program, Yale Cancer Center
Departments & Organizations
Biological and Biomedical Sciences (BBS): Molecular Cell Biology, Genetics and Development | Molecular Medicine, Pharmacology, and Physiology
Cancer Prevention and Control Center
Skin Diseases Research Center, Yale
Pathology: Pathology Research
Signal Transduction
Research Interests
Cancer Biology: signal transduction by HER2/ErbB2 and other EGF family receptor tyrosine kinases; EGF family receptors in breast cancer and mammary development; DNA damage checkpoint signaling; Functional and genetic analysis of cancer; Melanoma more...
Education
- B.S., Massachusetts Institute of Technology, 06/1976
- Ph.D., University of California, San Diego, 1983
Selected Publications
- Wilson, K.A.*, Colavito*, S.A., Schulz, V., Wakefield T., Sessa W., Tuck, D. and D.F. Stern. 2011. NFBD1/MDC1 regulates Cav1 and Cav2 independently of DNA damage and p53. Mol Cancer Res 9:766-801. PMID: (21551225) *Authors contributed equally.
- Tworkoski, K., Singhal, G.*, Szpakowski*, S., Zito*, C.I., Bacchiocchi, A., Bosenberg, M, Krauthammer, M., Halaban, R., and D.F. Stern. 2011. Phospho-Proteomic Screen Identifies Potential Therapeutic Targets in Melanoma. Mol Cancer Res 9:801-12. PMID: (21521745)
- Gilmore-Hebert, M., Ramabhadran, R, and DF. Stern. 2010. Interactions of ErbB4 and Kap1 connect growth factor and DNA damage response pathways. Mol Cancer Res 8:1388-98. PMID: (20858735)
